Dossier Contents
- • Efficiency Score
- • Interaction Map
- • Priority Stack
EXIABIO
Most blood tests are built to detect illness. Exia Bio reads the same results for what is not yet optimal. Same results, one layer deeper.

Dossier Contents
Analysis Framework
Traditional bloodwork is built around binary reference ranges — it is designed to detect illness. Exia Bio reads the same results as a system: showing where biomarkers are optimal, stable, drifting, or carrying an early friction load before it becomes a clinical problem.

Sentinel calibration · Binary clinical range vs. five-zone performance calibration: warning, friction, stable, optimised, drift. Exia Bio does not replace consultation with a licensed healthcare professional — it adds a performance-friction layer for educational biomarker intelligence.
Most biomarker platforms are designed around Western-market assumptions. Exia Bio is being built from Singapore and Malaysia outward — with regional lab-report formats, bilingual communication, Asian-market customer journeys, and population-context awareness in mind.
Sentinel is not ethnicity-locked. It is designed for anyone using blood data in Singapore or Malaysia, including local residents, expatriates, Caucasian residents, and mixed-background users. The platform evaluates report context, marker completeness, missing signals, and pathway goals before deciding how much confidence the data can support.
Use the blood report you already have.
See where your system is under load.
Find out what your report does not yet cover.
Turn a snapshot into a trend with Continuity.
Use an existing screening report, complete missing markers, or or use a partner-supported collection pathway, where available.
Choose performance, gym, slimming, longevity, or multiple pathways.
See friction patterns, gaps, priority systems, and progression.
Start with Baseline Analysis or Deep Map using your existing report.
Launch access from S$99
Use Signal Unlock to complete advanced performance markers.
Phase 2 · In development
Choose Baseline Complete or Apex for a new baseline and partner-supported collection pathway.
Phase 2 · In development
Fictional illustration. Not real customer data. Not medical analysis.
A professional in Singapore submitted his company’s annual health screening — all markers within clinical reference ranges, nothing flagged. Sentinel read the same data as a system and identified a fasting insulin–LDL overlap consistent with early metabolic drift, plus a cortisol result at the drift boundary. None of this appeared on the standard clinical readout.
Within clinical range. Showing early friction. That is the gap Sentinel surfaces.
What users do with these insights — including whether to discuss them with a healthcare professional — is their decision. Exia Bio does not provide medical advice or clinical recommendations.
Entity
Exia Bio Pte. Ltd.
UEN
202611602N
Data
PDPA-aware handling
Output
Secure dashboard
Boundary
Non-diagnostic
Upload an existing report, complete missing markers, or or use a partner-supported collection pathway, where available. Exia Bio converts biomarker data into a secure dashboard for performance, body composition, recovery, and longevity.